Upgrade to SI Premium - Free Trial

Jefferies Not Concerned About 'Crown Use' of Vertex's (VRTX) Orkambi

February 1, 2019 8:27 AM
Jefferies analyst Michael Yee reiterated a Buy rating and $210 price target on Vertex (NASDAQ: VRTX) noting that on Feb ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA Trader Talk

Next Articles